Developed & Manufactured by Biomedica

High quality ELISAs
Developed and manufactured by Biomedica

Featured Products & Promotions

Latest News
  • Big ET-1 is a promising cardiotoxicity marker in childhood cancer survivors
    Big ET-1 is a promising cardiotoxicity marker in childhood cancer survivors
    19 May, 2026
    Big ET-1 is a promising cardiotoxicity marker in childhood cancer survivors Advancements in oncological therapies have resulted in a childhood cancer survivor (CCS) long-term survival rate exceeding 80%.  However, up to 60% of CCS are exposed to cardiotoxic treatments, significantly increasing their risk of congestive heart failure (CHF). CHF is a leading cause of long-term [...]
  • Paradoxical role of IL-6 in cancer
    Paradoxical role of IL-6 in cancer
    12 May, 2026
    Interleukin-6 (IL-6) is a cytokine involved in immune responses, inflammation, and metabolism. It is produced by various cells, including immune cells, adipocytes, and muscle tissue (1). In the context of cancer, IL-6 can function both as a promoter and an inhibitor of tumor growth. Skeletal muscle is a significant source of circulating IL-6 in individuals [...]
  • Customized Testing Solutions for ELISA, Luminex, and microRNA
    Customized Testing Solutions for ELISA, Luminex, and microRNA
    5 May, 2026
    Simplify Your Testing Process We at Biomedica provide tailored analytical testing services for ELISA Kits, Luminex Assays, and microRNA Analysis. Customized Testing Solutions for ELISA, Luminex, and microRNA Features: -Expert-Driven: All analyses conducted by experienced professionals  -High-Quality: Committed to delivering excellence in every test  -Flexible: Customized solutions designed to meet your specific requirements  -Efficient: Save [...]
More News
Events
  • Biomedica at Osteologie in Salzburg
    19 June, 2023
    Biomedica features FGF23 ELISA - intact and C-terminal - assays Meet us at the OSTEOLOGIE Conference taking place from 22-24 June 2023 in Salzburg, Austria! We will exhibit at booth # 36 introducing our novel biomarker ELISA assays to investigate bone and cancer induced bone diseases (e.g. Periostin, Semaphorin 4D, LRG, and others). Our focus [...]
  • Biomedica @ Osteologie 2020 in Salzburg
    17 February, 2020
    Meet us at the Osteologie 2020, hosted by the Deutsche Gesellschaft für Endokrinologie and the Österreichische Gesellschaft für Knochen- und Mineralstoffwechsel, taking place from 12-14 March 2020 in Salzburg, Austria! We will exhibit together with our partners Fianostics & TAmiRNA at booth #1. Moreover,  we will present out new VEGF-A ELISA at our poster "Novel VEGF-A ELISA [...]
  • Meet Biomedica at ASN Kidney Week
    7 November, 2019
    Meet us during ASN Kidney Week taking place from November 5-10 2019 in Washington, DC at booth no. 2005 Hosted by the American Society of Nephrology it’s the world’s premier nephrology meeting with more than 13,000 kidney specialists from across the globe. It provides participants with exciting and challenging opportunities to exchange knowledge, learn about [...]
More Events